Pfizer Strengthens Manufacturing Capabilities in Asia

Pfizer Inc.Pfizer Inc. (NYSE: PFE) announced a $100 million (U.S.) investment into the expansion of its Singapore Nutrition Plant, helping it continue to set the standard for the manufacture of high-quality, safe and environmentally sustainable nutritional products for infants and children. This expansion, which brings the total investment in the plant to $372 million (U.S.), makes it one of the largest nutritional plants worldwide.

The expansion of the plant to 91,963 square meters (the equivalent of 17 football fields) has boosted the plant's production capacity by 50 percent and increased the plant's ability to supply nutrition products to Singapore and key markets such as China, Indonesia, Malaysia, Pakistan, Sri Lanka, Thailand, Taiwan, Hong Kong and Vietnam.

"The expansion of our Singapore Nutrition Plant is one example of Pfizer's commitment to securing a healthy and sustainable future for our children," said Jeffrey B. Kindler, chairman and chief executive officer of Pfizer. "Our most valuable resources are our children and our environment, and Pfizer seeks to protect both by ensuring that our products for infants and children are manufactured to the most rigorous of safety and quality standards, with minimal environmental impact."

"Infant Formula is one of the most stringently regulated consumer products in the world," said Natale Ricciardi, senior vice president of Pfizer and president of Pfizer Global Manufacturing. "With about 120 colleagues working in Quality Operations alone, the plant maintains the highest quality and safety standards throughout every stage of the production process. Quality and compliance are critically important aspects of the Pfizer Global Manufacturing Culture."

As part of the plant expansion, Pfizer has added over 100 new positions in the past year, bringing its staff strength to 587 people in total.

The plant is part of Pfizer Global Manufacturing's Nutrition Operating Unit, a global Nutrition manufacturing network committed to setting the global quality standard for nutrition products used by infants and children. The network also operates manufacturing facilities in Ireland, China, Mexico and the Philippines.

The Pfizer Singapore Nutritional Plant achieves sustainability through the use of advanced technology aimed at maximizing energy efficiency and reducing waste. Over 50 percent of water used by the plant for maintenance purposes is recycled.

"Pfizer's expansion today marks another significant milestone in the long-standing Pfizer-Singapore partnership. Today's expansion also attests to Pfizer's continued confidence in Singapore as a location for global manufacturing excellence and business hub in the heart of dynamic Asia," said Mr. Lim Hng Kiang, minister for Trade & Industry, Singapore.

Formerly a Wyeth operation, the plant was integrated into Pfizer Singapore following Pfizer's acquisition of Wyeth in October 2009. The expansion was completed in June 2010.

"Today's announcement demonstrates Pfizer's commitment to health and well-being at all ages," said Erica Mann, president and general manager, Pfizer Nutrition. "With the expansion of the state-of-the-art plant, we believe the company is well positioned to broaden our Nutrition portfolio and better serve families across Asia."

Pfizer Inc: Working Together for a Healthier World™
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our commitments, please visit us at www.pfizer.com.

Pfizer was incorporated in Singapore in June 1964. We have over 1,200 employees, with more than 10 groups operating in Singapore.

Most Popular Now

Delivering insulin in a pill

Given the choice of taking a pill or injecting oneself with a needle, most of us would opt to regulate a chronic health condition by swallowing a pill. But for millions o...

Can aspirin treat Alzheimer's?

A regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological r...

Probiotics can protect the skeletons of older wome…

For the first time in the world, researchers at the University of Gothenburg, Sweden, have demonstrated that probiotics, dietary supplements with health-promoting bacteri...

Alzheimer's breakthrough: Brain metals that may dr…

Alzheimer's disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegen...

FDA approves first drug comprised of an active ing…

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms o...

Researchers develop a new method for turning skin …

Our bodies consist of many different kinds of cells, each with their own role. The Japanese scientist Shinya Yamanaka had made earlier the discovery, earning the Nobel Pr...

Some existing anti-cancer drugs may act in part by…

Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti...

FDA takes steps to foster greater efficiency in bi…

Today, the agency withdrew the draft guidance, "Statistical Approaches to Evaluate Analytical Similarity," issued in September 2017. The draft guidance, if finalized as w...

Poliovirus therapy for recurrent glioblastoma has …

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, wit...

Novartis Clear about Psoriasis survey data highlig…

Novartis announced today the publication of global Clear about Psoriasis survey data in the Journal of the European Academy of Dermatology and Venereology[1]. The publica...

Human clinical trial reveals verapamil as an effec…

Researchers at the University of Alabama at Birmingham Comprehensive Diabetes Center have discovered a safe and effective novel therapy to reduce insulin requirements and...

How targeting metabolism can defeat cancer stem ce…

Researchers are the University of Michigan Rogel Cancer are unraveling a crucial thread that explains why cancer so often becomes resistant to treatment. In a breakthroug...